These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28100873)

  • 41. MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload.
    Ji Y; Qiu M; Shen Y; Gao L; Wang Y; Sun W; Li X; Lu Y; Kong X
    Int J Mol Med; 2018 Apr; 41(4):1909-1916. PubMed ID: 29393356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2.
    Yuan J; Yuan G
    Mediators Inflamm; 2022; 2022():5187218. PubMed ID: 36060928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
    Guo H; Liu B; Hou L; The E; Li G; Wang D; Jie Q; Che W; Wei Y
    Int J Mol Med; 2015 May; 35(5):1159-68. PubMed ID: 25739102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
    Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
    Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
    PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts.
    Qi H; Ren J; E M; Zhang Q; Cao Y; Ba L; Song C; Shi P; Fu B; Sun H
    J Cell Mol Med; 2019 Mar; 23(3):1926-1939. PubMed ID: 30604587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.
    Yu YH; Hu ZY; Li MH; Li B; Wang ZM; Chen SL
    Int J Clin Exp Pathol; 2015; 8(3):2582-9. PubMed ID: 26045764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SLC26A4-AS1 Aggravates AngII-induced Cardiac Hypertrophy by Enhancing SLC26A4 Expression.
    Han X; Li C; Ji Q; Zhang L; Xie X; Shang H; Ye H
    Arq Bras Cardiol; 2023; 120(4):e20210933. PubMed ID: 37098982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA 26b encoded by the intron of small CTD phosphatase (SCP) 1 has an antagonistic effect on its host gene.
    Sowa N; Horie T; Kuwabara Y; Baba O; Watanabe S; Nishi H; Kinoshita M; Takanabe-Mori R; Wada H; Shimatsu A; Hasegawa K; Kimura T; Ono K
    J Cell Biochem; 2012 Nov; 113(11):3455-65. PubMed ID: 22678827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy
    Zhang Y; Ding Y; Li M; Yuan J; Yu Y; Bi X; Hong H; Ye J; Liu P
    Acta Pharm Sin B; 2022 May; 12(5):2374-2390. PubMed ID: 35646533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.
    Ge Y; Pan S; Guan D; Yin H; Fan Y; Liu J; Zhang S; Zhang H; Feng L; Wang Y; Xu R; Yin JQ
    Biochim Biophys Acta; 2013 Jan; 1832(1):1-10. PubMed ID: 23000971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
    Chiu CZ; Wang BW; Shyu KG
    J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4.
    Xiao Y; Zhang X; Fan S; Cui G; Shen Z
    PLoS One; 2016; 11(12):e0168078. PubMed ID: 27992564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
    Fu M; Zhang J; Xu S; Pang Y; Liu N; Tang C
    Chin Med Sci J; 2001 Mar; 16(1):1-4. PubMed ID: 12899339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression.
    Wang C; Wang S; Zhao P; Wang X; Wang J; Wang Y; Song L; Zou Y; Hui R
    J Cell Biochem; 2012 Jun; 113(6):2040-6. PubMed ID: 22275134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy.
    Feng HJ; Ouyang W; Liu JH; Sun YG; Hu R; Huang LH; Xian JL; Jing CF; Zhou MJ
    Braz J Med Biol Res; 2014 May; 47(5):361-8. PubMed ID: 24728214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.
    Wang Q; Yu X; Dou L; Huang X; Zhu K; Guo J; Yan M; Wang S; Man Y; Tang W; Shen T; Li J
    Oxid Med Cell Longev; 2019; 2019():8768164. PubMed ID: 31612078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Ming S; Shui-Yun W; Wei Q; Jian-Hui L; Ru-Tai H; Lei S; Mei J; Hui W; Ji-Zheng W
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29440459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.